The biochemistry of drug metabolism--an introduction: Part 2. Redox reactions and their enzymes
- PMID: 17372942
- DOI: 10.1002/cbdv.200790032
The biochemistry of drug metabolism--an introduction: Part 2. Redox reactions and their enzymes
Abstract
This review continues a general presentation of the metabolism of drugs and other xenobiotics started in a recent issue of Chemistry & Biodiversity. This Part 2 presents the numerous oxidoreductases involved, their nomenclature, relevant biochemical properties, catalytic mechanisms, and the very diverse reactions they catalyze. Many medicinally, environmentally, and toxicologically relevant examples are presented and discussed. Cytochromes P450 occupy a majority of the pages of Part 2, but a large number of relevant oxidoreductases are also considered, e.g., flavin-containing monooxygenases, amine oxidases, molybdenum hydroxylases, peroxidases, and the innumerable dehydrogenases/reductases.
Similar articles
-
The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes.Chem Biodivers. 2008 Nov;5(11):2171-336. doi: 10.1002/cbdv.200890199. Chem Biodivers. 2008. PMID: 19035562 Review.
-
The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.Chem Biodivers. 2009 May;6(5):591-684. doi: 10.1002/cbdv.200900022. Chem Biodivers. 2009. PMID: 19479846 Review.
-
FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics.Ann Pharm Fr. 2011 Jan;69(1):45-52. doi: 10.1016/j.pharma.2010.10.004. Epub 2010 Dec 28. Ann Pharm Fr. 2011. PMID: 21296217 Review.
-
The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.Chem Biodivers. 2008 Dec;5(12):2465-578. doi: 10.1002/cbdv.200890214. Chem Biodivers. 2008. PMID: 19089818 Review.
-
Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):895-921. doi: 10.1517/17425255.2.6.895. Expert Opin Drug Metab Toxicol. 2006. PMID: 17125408 Review.
Cited by
-
Computationally designed prodrugs of statins based on Kirby's enzyme model.J Mol Model. 2013 Sep;19(9):3969-82. doi: 10.1007/s00894-013-1929-2. Epub 2013 Jul 9. J Mol Model. 2013. PMID: 23835602
-
PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5).Am J Nucl Med Mol Imaging. 2012;2(1):29-32. Epub 2011 Dec 15. Am J Nucl Med Mol Imaging. 2012. PMID: 23133800 Free PMC article.
-
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS.Int J Mol Sci. 2022 Mar 26;23(7):3635. doi: 10.3390/ijms23073635. Int J Mol Sci. 2022. PMID: 35408998 Free PMC article.
-
Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells.Molecules. 2022 Dec 3;27(23):8514. doi: 10.3390/molecules27238514. Molecules. 2022. PMID: 36500603 Free PMC article.
-
In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401.Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):669-680. doi: 10.1007/s13318-019-00557-9. Eur J Drug Metab Pharmacokinet. 2019. PMID: 31030415
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources